Leadership & Management
‘You’ve earned your seat at the table…use it,’ says Sue Martin, former MD of J&J MedTech ANZ
Sue Martin, former Managing Director of Johnson & Johnson MedTech ANZ and Chair of the Medical Technology Association of Australia […]
MoreLeadership & Management
Lundbeck appoints new Managing Director in ANZ
Leadership & Management: Lundbeck has named Cara Dignum as the new Managing Director for Lundbeck Australia and New Zealand, succeeding […]
MoreLeadership & Management
Sanofi ANZ appoints Liz Selby as Country Lead after serving as acting leader
Leadership & Management: Sanofi has appointed Liz Selby as the Country Lead and Head of Pharma ANZ, with immediate effect. […]
MoreLeadership & Management
Chair of Medicines Australia bids farewell, leaving a legacy as a fearless leader
Leadership & Management: Dr Anna Lavelle AM FTSE has announced her departure as Chair of Medicines Australia, marking the end […]
MoreLeadership & Management
Medicines Australia strengthens leadership with new Board Directors amid HTA reform push
Medicines Australia has announced the appointment of five new Directors to its Board, alongside the re-appointment of Adam Roach for […]
MoreLeadership & Management
Boehringer Ingelheim GM tapped for global role following major successes in ANZ
Leadership & Management: Boehringer Ingelheim Australia and New Zealand’s General Manager, Dirk Otto, will assume the role of Head of […]
MoreLeadership & Management
Bayer ANZ restructures leadership team as vision for streamlined organisation takes shape
Leadership & Management: Bayer’s shift towards a “dynamic shared ownership” model is reshaping its operations in Australia and New Zealand, […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
MoreLeadership & Management
As reputational risks surge, why are so few companies equipped to tackle the issues?
In an increasingly interconnected yet deeply divided world, reputation management has become a labyrinth of challenges for organisations. As companies […]
MoreLeadership & Management
Astellas Nirelle Tolstoshev to run for Medicines Australia Board as leadership changes unfold
Recently appointed General Manager of Astellas Australia, Nirelle Tolstoshev, has announced her candidacy for a position on the Board of […]
MoreRecent Posts in Pharma, MedTech & Biotech
Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks
December 11, 2024
in News & Trends - Pharmaceuticals
‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia
December 11, 2024
in News & Trends - MedTech & Diagnostics
BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
December 11, 2024
in News & Trends - Pharmaceuticals
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
December 10, 2024
in Communication
Health insurers must refund gouged members’ profits: APHA CEO urges Health Minister to take firm action
December 10, 2024
in News & Trends - MedTech & Diagnostics
MTAA announces new Board Chair and Vice Chairs
December 10, 2024
in News & Trends - MedTech & Diagnostics
UCB nabs TGA approval for first dual action anti-seizure therapy
December 10, 2024
in News & Trends - Pharmaceuticals
Health Minister’s warning to private health insurers: ‘Stop this practice immediately, or I’ll force you to stop’
December 9, 2024
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - Pharmaceuticals
Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks
Obesity remains a pressing public health issue, serving as a key driver of numerous complications, including atherosclerotic cardiovascular disease (ASCVD) […]
MoreNews & Trends - MedTech & Diagnostics
‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia
The private healthcare sector is grappling with escalating tensions between private hospitals and health insurers, with no resolution in sight. […]
MoreNews & Trends - Pharmaceuticals
BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
Bruton tyrosine kinase (BTK) inhibitors have improved treatment outcomes for patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
More